Conduit Pharmaceuticals Inc (NASDAQ: CDT) – Not A Clear Buying Opportunity?
Conduit Pharmaceuticals Inc (CDT) concluded trading on Wednesday at a closing price of $0.78, with 3.37 million shares of worth about $2.63 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -92.82% during that period and on April 16, 2025 the price saw a […]